New Delhi: Novavax, the fourth vaccine for 12 to 18-year-olds in the country, has been approved. The DCGI approved the immediate use of the vaccine. This has been confirmed by the Serum Institute of India and Novavax.
The vaccine is developed by the Serum Institute. Adar Poonawala, CEO of the Serum Institute, said he was pleased that the protein-based vaccine was approved for adolescents.

Covid vaccine for 12-18, Covovax approved
Must Read
Arrest Made in RCB Victory Celebration Tragedy
In connection with the tragic incident at the Chinnaswamy Stadium during RCB’s IPL victory celebration, where 11 people lost their lives due to overcrowding,...